Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,376
Total Claims
$1.3M
Drug Cost
372
Beneficiaries
$3,431
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-85%
Opioid rate vs peers
0.3% vs 2.2% avg
+143%
Cost per patient vs peers
$3,431 vs $1,411 avg
+52%
Brand preference vs peers
16.2% vs 10.6% avg
Opioid Prescribing
0.3%
Opioid Rate
37
Opioid Claims
$1,083
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,834 claims · $729K
Generic: 9,495 claims · $545K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Abiraterone Acetate | 11 | $94K |
| Fluticasone/Umeclidin/Vilanter | 132 | $88K |
| Empagliflozin | 127 | $74K |
| Lipase/Protease/Amylase | 30 | $50K |
| Atorvastatin Calcium | 933 | $47K |
| Paliperidone Palmitate | 12 | $42K |
| Apixaban | 63 | $32K |
| Rifaximin | 11 | $32K |
| Dulaglutide | 29 | $29K |
| Insulin Glargine-Yfgn | 209 | $24K |
| Metformin Hcl | 51 | $23K |
| Rivaroxaban | 52 | $23K |
| Fluticasone/Vilanterol | 53 | $21K |
| Rosuvastatin Calcium | 255 | $21K |
| Pantoprazole Sodium | 339 | $20K |
Prescribing Profile
Patient Profile
75
Avg Age
63%
Female
2.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data